|
|
| August 25, 2017: Dr. Michael Ezekowitz and Dr. C. Michael Gibson Discuss: Apixaban vs conventional therapy in anticoagulation-naive patie |
Dr. Michael Ezekowitz and Dr. C. Michael Gibson Discuss: Apixaban vs conventional therapy
in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The
EMANATE Trial
TBD
[ Download video ] |
|
No comments have been submitted
|